Table 3.
Characteristic | No. patients | Percent | ||
---|---|---|---|---|
Age | ||||
< 40 | 1 | 0.10 | ||
40–49 | 71 | 7.37 | ||
50–59 | 440 | 45.69 | ||
60–69 | 431 | 44.76 | ||
70–79 | 20 | 2.08 | ||
| ||||
Gleason score | ||||
≤ 6 | 468 | 48.60 | ||
7 | 366 | 38.01 | ||
≥ 8 | 128 | 13.29 | ||
Missing | 1 | 0.00 | ||
| ||||
PSA at diagnosis (ng/mL) | ||||
0–2.5 | 30 | 3.12 | ||
2.51–4.0 | 54 | 5.61 | ||
4.1–6.0 | 247 | 25.65 | ||
6.1–10.0 | 316 | 32.81 | ||
> 10.0 | 316 | 32.81 | ||
| ||||
Time to recurrence | ||||
≤ 3 years | 636 | 65.01 | ||
> 3 years | 337 | 34.99 |